Lactobacillus Farciminis and Hyperalgesia

Lallemand

Status and phase: Completed; Phase 1

Conditions: Inflammation; Pain

Treatments: Drug: Placebo; Drug: Lactobacillus farciminis

Study type: Interventional

Funder types: Industry

Identifiers

NCT00852865

2008-A01380-55

HN 08-17

Details and patient eligibility

About

We want to analyse a possible effect of o dialy consumption of Lactobacillus farciminis on a hyperalgesia on response to thermal stimulation. A comparaison of results before and after three weeks of treatment will be made.

Enrollment: 48 patients

Sex: All

Ages: 18 to 60 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• healthy volunteers

Exclusion criteria

• consumption of yogurts

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

48 participants in 2 patient groups, including a placebo group

1

Experimental group

Description:

24 healthy volunteers consuming L.farciminis during three weeks

Treatment:

Drug: Lactobacillus farciminis

2

Placebo Comparator group

Description:

24 healthy volunteers consuming placebo during three weeks

Treatment:

Drug: Placebo